Good performance of an immunoassay based method for nevirapine measurements in human breast milk

Clinical Chemistry and Laboratory Medicine

Volumn 49, Issue 7, 2011, Pages 1171-1175

  Salado Rasmussen, Kirsten ^a   Theilgaard, Zahra Persson ^a   Chiduo, Mercy ^b   Pedersen, Court ^c   Gerstoft, Jan ^a   Katzenstein, Terese Lea ^a  

^a Rigshospitalet   (Denmark)

^b NATIONAL INSTITUTE OF MEDICAL RESEARCH   (Tanzania)

^c UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

Author keywords

antiretroviral drug; breast milk; immunoassay; nevirapine

Indexed keywords

EMTRICITABINE PLUS TENOFOVIR DISOPROXIL; LAMIVUDINE PLUS ZIDOVUDINE; NEVIRAPINE;

ACCURACY; ARTICLE; BREAST MILK; CALIBRATION; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG SELECTIVITY; DRUG STABILITY; FEMALE; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOASSAY; LIMIT OF QUANTITATION; PRIORITY JOURNAL; QUALITY CONTROL; SINGLE DRUG DOSE; VALIDATION STUDY;

CALIBRATION; FEMALE; HUMANS; IMMUNOASSAY; LIMIT OF DETECTION; MILK, HUMAN; NEVIRAPINE; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS;

EID: 79960210835     PISSN: 14346621     EISSN: 14374331     Source Type: Journal    
DOI: 10.1515/CCLM.2011.184     Document Type: Article

References (13)

1. Nduati R, John G, Mbori-Ngacha D, Richardson B, Overbaugh J, Mwatha A, et al. Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. J Am Med Assoc 2000;283:1167-74 (Pubitemid 30126605)
2. World Health Organization. 10 Facts on breastfeeding. Available at: http://www.who.int/features/factfiles/breastfeeding/facts/en/index5.html. Accessed Dec 6, 2010
3. Guay LA, Musoke P, Fleming T, Bagenda D, Allen M, Nakabiito C, et al. Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial. Lancet 1999;354:795-802 (Pubitemid 29415583)
4. Kumwenda NI, Hoover DR, Mofenson LM, Thigpen MC, Kafulafula G, Li Q, et al. Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 2008;359: 119-29 (Pubitemid 351962035)
5. Rezk NL, Abdel-Megeed MF, Kashuba AD. Development of a highly efficient extraction technique and specific multiplex assay for measuring antiretroviral drug concentrations in breast milk. Ther Drug Monit 2007;29:429-36 (Pubitemid 47220460)
6. Rossi DT, Wright DS. Analytical considerations for trace determinations of drugs in breast milk. J Pharm Biomed Anal 1997;15:495-504 (Pubitemid 26384304)
7. van Heeswijk RP, Veldkamp AI, Mulder JW, Meenhorst PL, Wit FW, Reiss P, et al. Nevirapine plus didanosine: once or twice daily combination? J Acquir Immune Defic Syndr 2000; 25:93-5
8. Holland DT, Espina-Quinto R, Stefanski EK, Moon B, Valdez J, Connor JD. Rapid automated immunoassay for therapeutic drug monitoring of nevirapine using ARK NVP-test: method validation, application and comparison with HPLC method wabstractx. ICCAC 2005:A34
9. Salado-Rasmussen K, Theilgaard Z, Chiduo M, Pedersen C, Lemnge M, Gerstoft J, et al. Evaluation of a sample-sparing assay for nevirapine (NVP) measurements as an alternative to the high-performance liquid chromatography (HPLC) method wabstractx. IAS 2009:CDC008. Available at: http://www.ias2009.org/ pag/Abstracts.aspx?AIDs641. Accessed Dec 6, 2010
10. Katzenstein TL, Gerstoft J. Backup with Combivir or single dose (SD) Truvada in order to avoid non-nucleoside reverse transcriptase inhibitor (NNRTI) resistance after SD nevirapine for the prevention of mother-to-child transmission (PMTCT). Available at: http://clinicaltrials.gov/ct2/show/study/ NCT0034 6567?termscomtru&ranks1. Accessed Dec 6, 2010
11. Food and Drug Administration. Guidance for industry, bioanalytical method validation. US Department of Health and Human Services. Available at: http://www.fda.gov/downloads/Drugs/GuidanceComplianceRegulatoryInformation/ Guidances/UCM070107.pdf. Accessed Dec 6, 2010
12. Shah VP, Midha KK, Findlay JW, Hill HM, Hulse JD, Mc- Gilveray IJ, et al. Bioanalytical method validation - a revisit with a decade of progress. Pharm Res 2000;17:1551-7 (Pubitemid 32217566)
13. Hudelson SE, McConnell MS, Bagenda D, Piwowar-Manning E, Parsons TL, Nolan ML, et al. Emergence and persistence of nevirapine resistance in breast milk after single-dose nevirapine administration. AIDS 2010;24:557-61